Itri, a partner and one of the leaders of the the firm’s qui tam practice, focuses her nationwide practice on representing plaintiffs in whistleblower cases and class action securities, consumer and fraud cases.

In 2019, Itri was the lead attorney in multiple False Claims Act settlements. She represented one of the whistleblowers in a case against UTC Laboratories (RenRX) and its three principals, who, in October 2019, agreed to pay $42.6 million to resolve allegations that they violated the False Claims Act by paying kickbacks in exchange for laboratory referrals for pharmacogenetic testing.